ADARE Trademark

Trademark Overview


On Wednesday, April 19, 2017, a trademark application was filed for ADARE with the United States Patent and Trademark Office. The USPTO has given the ADARE trademark a serial number of 87416905. The federal status of this trademark filing is REGISTERED as of Tuesday, June 8, 2021. This trademark is owned by Adare Pharmaceuticals, Inc.. The ADARE trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing of oral drug delivery formulations, to the specifications of others, used as facilitating agents for pharmaceutical tablets and capsules, vitamins, food supplements, and animal veterinary tablets and capsules

Design and development of pharmaceutical formulations; Research and development of oral drug delivery formulation used as facilitating agents for pharmaceutical tablets and capsules, vitamins, food supplements, and animal veterinary tablets and capsules; Development of pharmaceutical preparations in liquid time release form
adare

General Information


Serial Number87416905
Word MarkADARE
Filing DateWednesday, April 19, 2017
Status700 - REGISTERED
Status DateTuesday, June 8, 2021
Registration Number6380519
Registration DateTuesday, June 8, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "ADARE" with the second capital "A" in the word dissected in the middle by a circle located above the bottom half of the "A" and containing the top half of the "A", in triangle form.
Goods and ServicesManufacturing of oral drug delivery formulations, to the specifications of others, used as facilitating agents for pharmaceutical tablets and capsules, vitamins, food supplements, and animal veterinary tablets and capsules
Goods and ServicesDesign and development of pharmaceutical formulations; Research and development of oral drug delivery formulation used as facilitating agents for pharmaceutical tablets and capsules, vitamins, food supplements, and animal veterinary tablets and capsules; Development of pharmaceutical preparations in liquid time release form

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, April 25, 2017
Primary Code040
First Use Anywhere DateSunday, March 31, 2019
First Use In Commerce DateSunday, March 31, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 25, 2017
Primary Code042
First Use Anywhere DateSunday, March 31, 2019
First Use In Commerce DateSunday, March 31, 2019

Trademark Owner History


Party NameAdare Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Party NameAdare Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Party NameAdare Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Trademark Events


Event DateEvent Description
Tuesday, June 8, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, May 6, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 5, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 3, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 28, 2021USE AMENDMENT FILED
Wednesday, April 28, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, November 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 9, 2020EXTENSION 5 GRANTED
Monday, November 2, 2020EXTENSION 5 FILED
Monday, November 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 2, 2020TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 24, 2020EXTENSION 4 GRANTED
Friday, April 24, 2020EXTENSION 4 FILED
Friday, April 24, 2020TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2019EXTENSION 3 GRANTED
Friday, November 1, 2019EXTENSION 3 FILED
Friday, November 1, 2019TEAS EXTENSION RECEIVED
Saturday, April 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 25, 2019EXTENSION 2 GRANTED
Thursday, April 25, 2019EXTENSION 2 FILED
Thursday, April 25, 2019TEAS EXTENSION RECEIVED
Thursday, September 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 18, 2018EXTENSION 1 GRANTED
Tuesday, September 18, 2018EXTENSION 1 FILED
Tuesday, September 18, 2018TEAS EXTENSION RECEIVED
Tuesday, May 1, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, January 28, 2018ASSIGNED TO LIE
Thursday, January 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, January 17, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 17, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, January 17, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, July 24, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 24, 2017NON-FINAL ACTION E-MAILED
Monday, July 24, 2017NON-FINAL ACTION WRITTEN
Friday, July 14, 2017ASSIGNED TO EXAMINER
Wednesday, April 26, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, April 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 22, 2017NEW APPLICATION ENTERED IN TRAM